Global Cardiovascular Innovation Center-医療機器分野:企業M&A・提携分析

◆英語タイトル:Global Cardiovascular Innovation Center - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011687
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Global Cardiovascular Innovation Center (GCIC) is a healthcare service provider that offers medical technology services. The organization designs, manufactures and distributes cardiovascular products and technologies. It has an incubator facility to help start up companies in developing advanced solutions for the diagnosis and treatment of cardiovascular disease. GCIC provides programs such as commercialization funding program, incubator program, and preclinical research and development facilities. The organization’s preclinical research and development facilities offers interventional and surgical resources to researchers, clinical investigators, interventionalists and surgeons for testing the next generation of devices and procedures, among others. GCIC is headquartered in Cleveland, Ohio, the US.

Global Cardiovascular Innovation Center – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Global Cardiovascular Innovation Center, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Global Cardiovascular Innovation Center, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Global Cardiovascular Innovation Center, Medical Equipment, Deal Details 10
Venture Financing 10
Securus Medical Raises USD10 Million in Series C Financing 10
Vectorious Medical Raises USD5 Million in Venture Financing 12
Juventas Therapeutics Raises US$22.2 Million In Series B Venture Financing Round 13
Global Cardiovascular Innovation Center – Key Competitors 15
Global Cardiovascular Innovation Center – Key Employees 16
Global Cardiovascular Innovation Center – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Global Cardiovascular Innovation Center, Medical Equipment, Key Facts 2
Global Cardiovascular Innovation Center, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Global Cardiovascular Innovation Center, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Global Cardiovascular Innovation Center, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Global Cardiovascular Innovation Center, Deals By Market, 2011 to YTD 2017 8
Global Cardiovascular Innovation Center, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Securus Medical Raises USD10 Million in Series C Financing 10
Vectorious Medical Raises USD5 Million in Venture Financing 12
Juventas Therapeutics Raises US$22.2 Million In Series B Venture Financing Round 13
Global Cardiovascular Innovation Center, Key Competitors 15
Global Cardiovascular Innovation Center, Key Employees 16

★海外企業調査レポート[Global Cardiovascular Innovation Center-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Milagen Inc:企業の製品パイプライン分析
    Summary Milagen Inc (Milagen) is a medical device company. It provides diagnostic products. The company generates antibody reagents against the human proteome. It discovers, develops and markets non invasive immunodiagnostic products for monitoring, surveillance and detection of cancers. Milagen off …
  • Equinor ASA (EQNR):企業の財務・戦略的SWOT分析
    Equinor ASA (EQNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Petronas Dagangan Berhad (PETDAG):企業の財務・戦略的SWOT分析
    Petronas Dagangan Berhad (PETDAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Shenogen Pharma Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shenogen Pharma Group Ltd (Shenogen) is a drug discovery and development company that develops therapeutics for cancer treatment. The company develops biologic drugs and small molecule targeted at the new estrogen receptor variant. It provides SNG-162 that is a small molecule naturally deriv …
  • Zensar Technologies Limited (ZENSARTECH):企業の財務・戦略的SWOT分析
    Zensar Technologies Limited (ZENSARTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • InspireMD Inc (NSPR):医療機器:M&Aディール及び事業提携情報
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Serodus ASA (SER)-製薬・医療分野:企業M&A・提携分析
    Summary Serodus ASA (Serodus) is a drug development company that focuses on the development of products for unmet medical needs in areas such as diabetes and diabetic comorbidities. The company’s pipeline products include SER150DN, an anti-inflammatory compound under development for diabetic nephrop …
  • Alamos Gold Inc:企業の戦略・SWOT・財務分析
    Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Open Text Corporation (OTEX):企業の財務・戦略的SWOT分析
    Open Text Corporation (OTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • NRG Energy Inc (NRG):電力:M&Aディール及び事業提携情報
    Summary NRG Energy, Inc. (NRG) is an integrated energy company that produces, sells and delivers energy products and services. The company generates power using diverse sources such as coal, natural gas, nuclear, oil, wind and solar. It trades wholesale energy, capacity, fuel and related products. T …
  • Vestagen Protective Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Vestagen Protective Technologies Inc (Vestagen), formerly Vestagen Technical Textiles Inc, is a medical technology company. The company develops, manufactures and markets textile products and technologies for uniforms and other apparel for specialty healthcare workers, patients and other occ …
  • The Hartford Financial Services Group, Inc.:戦略・SWOT・企業財務分析
    The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Noble Corporation Plc (NE):企業の財務・戦略的SWOT分析
    Noble Corporation Plc (NE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Xencor Inc (XNCR):製薬・医療:M&Aディール及び事業提携情報
    Summary Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company that develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the …
  • Owlstone Medical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Owlstone Medical Ltd (Owlstone Medical), formerly Tiger Dawn Ltd, is a diagnostic company. The company develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications; Lonestar for disease biomarker detect …
  • Thomas Cook Group plc (TCG):企業の財務・戦略的SWOT分析
    Thomas Cook Group plc (TCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Global Partners LP (GLP)-石油・ガス分野:企業M&A・提携分析
    Summary Global Partners LP (Global Partners) is a midstream logistics and marketing company. It carries out purchasing, selling and logistics of transporting domestic and Canadian crude oil and other products by rail across its virtual pipeline from the mid-continent region of the US and Canada to t …
  • Fidia farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Fidia farmaceutici SpA (Fidia), a subsidiary of P&R S.p.A., is a healthcare products provider that specializes in research, development and manufacturing of hyaluronic acid-based products. The company develops and commercializes products for specific therapeutic areas which includes joint he …
  • Oriental Hotels Ltd
    Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Oriental Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Munchener Ruckversicherungs-Gesellschaft AG (Munich Re):戦略・SWOT・企業財務分析
    Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) - Strategy, SWOT and Corporate Finance Report Summary Munchener Ruckversicherungs-Gesellschaft AG (Munich Re) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆